- - Sunday, June 6, 2021

As mentioned in “Trump Derangement Syndrome: Was Hydroxychloroquine unfairly discredited?” (Web, June 2) Hydroxychloroquine (Plaquenil) was dismissed as an effective treatment because then-President Trump spoke of its promise. In fact, the FDA actually banned its use for COVID-19. Almost all studies (NEJM, Lancet, JAMA, etc.) were improperly done when giving the drug to hospitalized patients. These people were already in cytokine storm, and the most important adjuvant therapy, zinc, was not added to their treatment.

Plaquenil, ivermectin and quercetin are “ionophore” drugs that potentiate zinc entering cells and binding with viral polymerase, thereby inhibiting viral replication. As a practicing ophthalmologist with over 47 years of experience following patients on Plaquenil, I can attest to its safety for short-term use. It even has an “A” rating for safety during pregnancy. Dr. Harvey Risch, professor of epidemiology at Yale University, suggested that 95% of lives would have been saved if Plaquenil or ivermectin had been given with zinc early in the disease — and I and many of my colleages concur with his opinion.

JAY KATZEN

Potomac, Md.

Sign up for Daily Opinion Newsletter

Manage Newsletters

Copyright © 2021 The Washington Times, LLC. Click here for reprint permission.

Please read our comment policy before commenting.

 

Click to Read More and View Comments

Click to Hide